Sarepta Therapeutics (SRPT) EBITDA Margin Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -40,178.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 530.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -932.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 7,003.00 |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn | 29,290.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29,290.00 |
| Dec 31, 2025 | -2,926.00 |
| Sep 30, 2025 | 7,940.00 |
| Jun 30, 2025 | 14,284.00 |
| Mar 31, 2025 | 25,329.00 |
| Dec 31, 2024 | 13,349.00 |
| Sep 30, 2024 | 3,333.00 |
| Jun 30, 2024 | 5,908.00 |
| Mar 31, 2024 | 12,218.00 |
| Dec 31, 2023 | 85,178.00 |
| Sep 30, 2023 | 86,136.00 |
| Jun 30, 2023 | 47,157.00 |
| Mar 31, 2023 | -7,544.00 |
| Dec 31, 2022 | 17,180.00 |
| Sep 30, 2022 | 316.00 |
| Jun 30, 2022 | 18,127.00 |
| Mar 31, 2022 | -39,063.00 |
| Dec 31, 2021 | 5,810.00 |
| Sep 30, 2021 | 7,143.00 |
| Jun 30, 2021 | 9,083.00 |
| Mar 31, 2021 | -5,869.00 |
| Dec 31, 2020 | -79,905.00 |
| Sep 30, 2020 | -76,976.00 |
| Jun 30, 2020 | -40,200.00 |
| Mar 31, 2020 | -64,288.00 |
| Dec 31, 2017 | 16.46 Mn |
| Sep 30, 2017 | 265,794.00 |
| Jun 30, 2017 | 113,047.00 |
| Mar 31, 2017 | 98,034.00 |